Unresectable Head and Neck Squamous Cell Carcinoma

12 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Unresectable Head and Neck Squamous Cell Carcinoma

Record	Firm	Date
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer (NCT04576091)	National Cancer Institute (NCI)	2022-07-06
Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer (NCT04834349)	M.D. Anderson Cancer Center	2021-03-09
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 (NCT04534205)	BioNTech SE	2021-01-07
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer (NCT04870840)	M.D. Anderson Cancer Center	2020-10-19
Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat (NCT03823131)	Chase Heaton, MD	2019-05-02
Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer (NCT03468218)	Emory University	2018-09-18
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma (NCT03229278)	Rutgers, The State University of New Jersey	2017-10-03
Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery (NCT01468896)	National Cancer Institute (NCI)	2011-10-26

Track Unresectable Head and Neck Squamous Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.